Global Disease Detection Operations Center: Outbreaks
Five top global infectious disease threats for 2012
Five of the top global infectious disease threats for 2012 that we were watching, were: Avian influenza A (H5N1), cholera, poliomyelitis (Polio), enterovirus-71 and extensively drug-resistant tuberculosis. A perspective from the GDD Operations Center describes these threats in this publication - Emerg Health Threats J 2013, 6: 20632 - http://dx.doi.org/10.3402/ehtj.v6i0.20632
International Outbreaks – 2013
The GDD Operations Center monitors approximately 30–40 public health threats each day. In 2013, the GDD Operations Center monitored and reported on over 100 unique outbreaks of more than 30 diseases occurring in more than 65 different countries with additionally a cumulative of close to 550 disease event updates to the CDC wide readership. Examples of disease events that GDD Operations Center was closely watching in 2013 are: avian influenza H5N1 in multiple countries and H7N9 in China; Middle East Respiratory Syndrome-coronavirus in multiple countries; Polio in endemic countries, the Horn of Africa and Syria; cholera in Cuba and Mexico; chikungunya fever in the Americas and Southern Pacific Ocean; dengue and yellow Fever in multiple countries; and Hepatitis E in South Sudan.
In 2013, the GDD Operation Center continued its support for the investigations first began in 2009 of a mystery illness subsequently characterized as Nodding Syndrome, a novel neurologic illness among children between 5-15 years, occurring in South Sudan, northern Uganda and southern Tanzan
Uganda to ascertain burden and geographic distribution of the illness. CDC and MoH Uganda jointly propose to assess treatment efficacy of antiepileptic medications and pyridoxine supplementation with the Nodding Syndrome treatment trial. CDC continues to work closely with the MoH of the three affected countries in identifying the etiology of this mystery illness. GDD Operations Center is providing the operational, logistical and technical support in consultation with DHCPP/NCEZID.